Trial Profile
Phase I study of NS2 eye drop in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Mar 2015
Price :
$35
*
At a glance
- Drugs Reproxalap (Primary)
- Indications Uveitis
- Focus Adverse reactions
- 20 Mar 2015 New trial record